In-Season Prevalence and Management of Hip and Groin Injuries in Competitive Athletes
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 30
- 主要终点
- Consent Proportion
研究概览
简要总结
This study is focused on helping athletes with a common hip condition called femoroacetabular impingement (FAI) syndrome. FAI syndrome occurs when abnormal bone shapes around the hip joint cause friction during movement, leading to pain, reduced performance, and, over time, more serious injury. While this issue is well-studied in male professional athletes, little is known about how it affects female and collegiate athletes, or how to prevent it from worsening.
In this study, athletes diagnosed with FAI syndrome will participate in a 12-week in-season exercise program designed to reduce pain, improve hip strength and movement, and help prevent further injury-all while continuing their regular sports training.
Participants will be randomly assigned to either:
- An exercise group (receiving the intervention), or
- A time-and-attention control group (regular check-ins and education).
At the end of the study, the control group will have the option to access the exercise program.
The study will track changes in pain, physical performance, injury recurrence, and athlete satisfaction with the program. This research aims to improve how we manage hip injuries in athletes and help keep them active during the competitive season.
详细描述
Study Rationale Femoroacetabular impingement (FAI) syndrome is a common source of hip pain in athletes participating in cutting, pivoting, and high-impact sports such as soccer, basketball, ice hockey, and ringette. It is characterized by abnormal contact between the femoral head and acetabulum, which may lead to cartilage damage, labral tears, and early osteoarthritis. While research has primarily focused on male professional athletes, there is limited evidence regarding the early management of FAI in younger, female, and collegiate athletes.
Current management strategies often emphasize post-season rehabilitation or surgical interventions, limiting opportunities to explore conservative strategies that allow continued play during the competitive season. This randomized controlled trial (RCT) addresses that gap by evaluating a novel, in-season, 12-week exercise intervention designed to mitigate symptoms, maintain sport participation, and potentially delay or reduce long-term structural damage.
Study Objectives
- Evaluate the feasibility of implementing an in-season, supervised exercise program in athletes with FAI syndrome.
- Explore preliminary effectiveness signals on functional outcomes and symptom progression.
Study Design Participants diagnosed with FAI syndrome based on clinical evaluation and symptom history will be randomized to either the intervention or a time-and-attention control group. The intervention group will complete a structured neuromuscular and hip-specific rehabilitation program, while the control group receives educational support and a progressive mobility and recovery (PMR) option during the same 12-week period. Randomization ensures balanced comparison of feasibility and clinical endpoints.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 14 Years 至 40 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •currently identifies as a "competitive athlete" based on the LTAD
- •aged 14-40
- •be free from any significant lower extremity injury (hip, groin, knee, ankle foot) in the past 6 months that resulted in >1 months of time loss or current inability to fully participate in sport at the time of baseline testing
- •If participants meet the above criteria, can be screened:
- •completed bilateral hip screen, including imaging, and identified as having FAI syndrome with no degenerative joint changes (if meet the remaining criteria,
排除标准
- •Are currently experiencing or recovering from a lower extremity injury that resulted in >1 month time lost within the past 6 months
- •are pregnant or may become pregnant during the study (due to radiographic imaging exposure)
- •* participants will be excluded from eligibility of RCT if they have evidence of moderate to severe osteoarthritis on imaging (Tönnis grade 2-3)
结局指标
主要结局
Consent Proportion
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
Number of participants screened positive and agreed to participate in intervention/number screened positive for inclusion
Proportion of Agreement to Screening
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
the number of participants whom agree to be screened/the number of participants approached for recruitment
Eligibility Proportion
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
the number screened positive for inclusion (evidence of FAI syndrome)/number of participants who agreed to be screened (consented)
Randomization Proportion
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
The number of participants randomized/the number of participants screened positive and agreed to participate
Trial-Arm Selection Proportion
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
The number agreed to each trial arm after randomization/the number of participants randomized
Attrition Proportion
时间窗: up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention
The number of participants who drop out of study/number of participants randomized in each arm
次要结局
- Special Test Findings(12 weeks)
- Make (Isometric) Strength Testing of the Hip(12 weeks)
- International Hip Outcome Tool (iHOT-33)(12 weeks)
- Copenhagen Hip and Groin Outcome Tool (HAGOS)(12 weeks)
- Passive Range of Motion(12 weeks)